Crowdonomics
WatchlistPortfolio
All companies
SynergyMed Cancer Treatment Technology logo

SynergyMed Cancer Treatment Technology

Operating

SynergyMed Devices Inc.

Healthcare · Technology · Founded 2019

Visit website

Ground breaking cancer treatment: Tumors vanish within feww days

Valuation cap ⓘ
$16.0M
As of Feb 2026 · from Reg CF Offering (2024) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$838,510
Crowd $698K · Private $141K · 3 rounds since 2020

Financials

FY2022–FY2023 · from SEC filings · hover any figure for its source
$0
−$21K
2022
$0
−$23K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$21,499
-$23,178
Taxes paid
$0
$0
Balance sheet
Cash
$65,920
$40,984
Accounts receivable
$0
$0
Total assets
$69,991
$48,713
Short-term debt
$0
$1,900
Long-term debt
$0
$0
Total liabilities
$0
$1,900
Other
Headcount
—
1

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Valuation caps on SAFE / convertible note rounds
$16.0M
Valuation cap
Reg CF · SAFE · Nov 2024

Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.

Fundraising history

Reg CF · SAFE · Nov 2024Closedvia WeFunder
Raised $698K / $1.2MValuation cap $16M
Reg D · Equity · Jun 2021Closed
Raised $100KInvestors 3
Reg D · Equity · Jan 2020Closed
Raised $40.5KInvestors 3

Team

1 person
Anan Copty
CEO

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 2 annual reports (FY2024–FY2025)

Missing: 2024, 2025

3 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C/AApr 30, 20250001670254-25-000515
    EDGAR
  • Form CNov 4, 20240001670254-24-001055
    EDGAR
  • Form DMay 26, 20220001811959-22-000002
    EDGAR
  • Form DMay 13, 20200001811959-20-000001
    EDGAR
Source: ManualCIK 0001811959

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.